# The Effect of CORT118335 on Olanzapine-Induced Weight Gain

> **NCT03877562** · PHASE1 · COMPLETED · sponsor: **Corcept Therapeutics** · enrollment: 96 (actual)

## Conditions studied

- Antipsychotic-induced Weight Gain

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** CORT118335
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03877562
- **Lead sponsor:** Corcept Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2020-03-13
- **Final completion:** 2020-03-25
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2020-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03877562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03877562, "The Effect of CORT118335 on Olanzapine-Induced Weight Gain". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03877562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*